"Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-85
SponsorAcibadem University
About this trial
The aim of this study is to evaluate the associations of self-compassion and self-efficacy levels with symptom severity, functional status, and quality of life in individuals with Parkinson's disease.
Eligibility criteria
Qualifiers
Clinical diagnosis of Parkinson's disease
Hoehn and Yahr stage 1-3
Age 40 to 85 years
Mini-Mental State Examination (MMSE) score ≥24
Disqualifiers
Major depressive disorder or psychotic disorder
Advanced dementia
Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension)
Severe cardiovascular or respiratory disease
Trial design
Treatments tested in this trial
- Self-Report Questionnaire Assessment
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov